$0.550
-0.007 (-1.33%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CTXR Prediction & Forecast by Similar Chart Analysis
Alphio's CTXR stock price prediction model matches the current Citius Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.55 (-0.43%). The 1-week path is $0.56 (+1.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Citius Pharmaceuticals Inc Stock?
Citius Pharmaceuticals Inc (CTXR) appears to be a good buy right now due to its current price of $0.55, which is significantly below its 52-week high of $1.54, suggesting potential for recovery. The company has recently reported a gross margin of 79.99% in Q1 2026, indicating strong profitability on sales, and analysts project a significant upside with a price target of $4. However, the main risk is the high net loss of $28.11 million in Q2 2026, which could impact future operations.
CTXR stock price ended at $0.55 on Friday, after losing -1.33%
Citius Pharmaceuticals Inc (CTXR) last closed at $0.55, losing -1.33%. These facts feed the 1-day and 1-week CTXR price prediction above.
Analyst Consensus
Citius Pharmaceuticals Inc (CTXR): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Citius Pharmaceuticals Inc (CTXR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CTXR, ranked by similarity.
Seasonality analysis for CTXR
Historically the probability of a positive November return for CTXR is 0.00%. April offers the highest probability of a positive month at 28.12%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.